ARCHIVES

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

This article is from The Cancer Letter archive.

Vol. 08 No. 32 | August 20, 1982

Download PDF Visit The Full Archive

Related Articles

Pazdur Waxes On Calumet City And Krebiozen; Parkinson Takes Interim CMO Job at Zyngenia

April 27, 2012

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

Funding opportunities listed.

June 18, 2004

NCI To Fund Partnerships Between Cancer Centers and Minority Institutions

November 12, 1999

Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted

September 6, 1974

Cancer Control Reps Discuss Issues of ‘80s

October 17, 1980